PLURISTEM THERAPEUTICS INC - COM (PSTI)

CUSIP: 72940R102

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
6,295,533
Share change
+422,656
Total reported value
$4,955,315
Put/Call ratio
29%
Price per share
$0.79
Number of holders
28
Value change
+$180,355
Number of buys
10
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 72940R102?
CUSIP 72940R102 identifies PSTI - PLURISTEM THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PLURISTEM THERAPEUTICS INC - COM (PSTI) as of Q4 2018

As of 31 Dec 2018, PLURISTEM THERAPEUTICS INC - COM (PSTI) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,295,533 shares. The largest 10 holders included ARK Investment Management LLC, RENAISSANCE TECHNOLOGIES LLC, ETF MANAGERS GROUP, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Psagot Investment House Ltd., GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES & ASSOCIATES, UBS Group AG, HERITAGE INVESTORS MANAGEMENT CORP, and HighTower Advisors, LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.